吉林大学学报(医学版) ›› 2017, Vol. 43 ›› Issue (04): 812-817.doi: 10.13481/j.1671-587x.20170428

• 临床医学 • 上一篇    下一篇

西黄胶囊辅助放化疗治疗中晚期食管癌患者的疗效评价

张宁, 王剑锋, 程光惠, 何明远   

  1. 吉林大学中日联谊医院放射治疗科, 吉林 长春 130033
  • 收稿日期:2017-02-16 出版日期:2017-07-28 发布日期:2017-08-01
  • 通讯作者: 程光惠,教授,博士研究生导师(Tel:0431-84995413,E-mail:chengguanghuifl@163.com) E-mail:chengguanghuifl@163.com
  • 作者简介:张宁(1991-),女,黑龙江省宁安市人,在读医学硕士,主要从事肿瘤放射治疗方面的研究。
  • 基金资助:
    国家自然科学基金资助课题(31600679);吉林省科技厅社发处科研项目资助课题(20090458);吉林省卫计委科研基金资助课题(2014ZC054);吉林省科技厅自然科学基金(白求恩专项)资助课题(20160101079JC);吉林大学研究生创新基金资助课题(2016223);吉林大学横向资助课题(2015373)

Evaluation on curative effect of Xihuang Capsule in patients with advanced esophageal cancer treated with chemoradiotherapy

ZHANG Ning, WANG Jianfeng, CHENG Guanghui, HE Mingyuan   

  1. Department of Radiation Oncology, China-Japan Union Hospital, Jilin University, Changchun 130033, China
  • Received:2017-02-16 Online:2017-07-28 Published:2017-08-01

摘要: 目的:探讨西黄胶囊辅助放化疗治疗中晚期食管癌患者的疗效及不良反应,阐明其作用机制。方法:选择未治的中晚期食管癌患者,通过筛选及剔除不满足本研究要求者,最后入组患者114例,其中接受西黄胶囊联合放化疗同期治疗的患者27例(联合治疗组);仅接受单纯放化疗治疗患者87例,随机抽取其中27例患者作为单纯放化疗组。观察时间均为放疗起始至第90天。比较2组患者生存质量评分(KPS)、吞咽困难程度及急性放射性食管炎的发生率、发生时间和严重程度分级,分析患者肿瘤局控情况。结果:治疗结束后,2组患者KPS评分均出现不同程度下降,但联合治疗组患者KPS评分明显高于单纯放化疗组(P<0.05)。治疗中晚期阶段,联合治疗组患者吞咽困难程度轻于单纯放化疗组(P<0.05),急性放射性食管炎的发生率亦低于单纯放化疗组(P<0.05),发生时间明显迟于单纯放化疗组(P<0.05),但2组患者急性放射性食管炎严重程度分级和肿瘤局控分级比较差异无统计学意义(P>0.05)。结论:西黄胶囊对中晚期食管癌患者生存质量起促进作用,同时可缓解患者吞咽困难程度,降低急性放射性食管炎的发生率并延缓其发生时间,可作为中晚期食管癌患者放化疗同期治疗的良好辅助用药。

关键词: 食管肿瘤, 西黄胶囊, 急性放射性食管炎, 吞咽困难

Abstract: Objective: To explore the curative effect and toxic and side effects of Xihuang Capsule in the patients with advanced esophageal cancer treated with chemoradiotherapy, and to clarify its mechanism.Methods: The patients with advanced esophagealcancer without treatment were selected. The patients treated with Xihuang Capsule combined with concurrent chemoradiotherapy were defined as combination treatment group(n=27), and then other 27 patients were randomly selected from 87 patients treated with concurrent chemoradiotherapy alone as chemoradiotherapy group. The observation time was 90 d from the begining of chemotherapy. The differences in KPS, degree of dysphagia, incidence, occurrence time and degrees of acute radiation esophagitis of the patients in two groups were compared, and local control of tumor was analyzed.Results: After treatment, the KPS scores of the pateints in two groups were decreased, and the KPS score in combined treatment group was significantly higher than that in chemoradiotherapy group (P<0.05). The grade of dysphagia of the patients in combined treatment group was lower than that in chemoradiotherapy group during the late period of treatment(P<0.05). The incidence of acute radiation esophagitis, the occurence time of acute radiation esophagitis of the patients in combination group was lower than that in chemoradiotherapy group (P<0.05);the occurrence time of acute radiation esophagitis was later than that in chemoradiotherapy group (P<0.05); but there were no significant differences in the grades of acute radiation esophagitis and tumor local control between two groups(P>0.05).Conclusion: Xihuang Capsule can improve the quality of life, reduce dysphagia degree and the incidence of acute radiation esophagitis,and delay the occurrence time;it can be used as an effective auxiliary treatment of advanced esophageal cancer.

Key words: esophageal neoplasms, acute radiation esophagitis, Xihuang Capsule, dysphagia

中图分类号: 

  • R735.1